title: Bullous Pemphigoid in Infancy Showing Epitope-spreading Phenomenon: Recovery with Topical Therapy.
authors.affiliation: Department of Dermatology, Kinki University Faculty of Medicine, 377-2 Ohno-Higashi, Osaka-Sayama, Osaka 589-8511, Japan.
authors.forename: Hiromasa
authors.initials: H
authors.lastname: Matsuda
authors.forename: Naoki
authors.initials: N
authors.lastname: Oiso
authors.forename: Norito
authors.initials: N
authors.lastname: Ishii
authors.forename: Masako
authors.initials: M
authors.lastname: Sato
authors.forename: Megumi
authors.initials: M
authors.lastname: Tatebayashi
authors.forename: Takashi
authors.initials: T
authors.lastname: Hashimoto
authors.forename: Akira
authors.initials: A
authors.lastname: Kawada
mesh_terms: D000287:Administration, Topical; D001623:Betamethasone / Q000627:therapeutic use*; D001707:Biopsy, Needle; D002990:Clobetasol / Q000031:analogs & derivatives / Q000627:therapeutic use; D018450:Disease Progression; D004359:Drug Therapy, Combination; D004797:Enzyme-Linked Immunosorbent Assay; D000939:Epitopes / Q000276:immunology*; D019085:Fluorescent Antibody Technique, Direct; D005500:Follow-Up Studies; D006801:Humans; D015151:Immunoblotting; D007150:Immunohistochemistry; D007223:Infant; D007564:Japan; D008297:Male; D010391:Pemphigoid, Bullous / Q000188:drug therapy* / Q000276:immunology / Q000473:pathology*; D018570:Risk Assessment; D012720:Severity of Illness Index; D016896:Treatment Outcome
chemical_list: D000939:Epitopes; C010893:clobetasone butyrate; D001623:Betamethasone; D002990:Clobetasol